May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Potential Improvement of Lentiviral Gene Transfer by Weakening The Extracellular Matrix
Author Affiliations & Notes
  • O. Grüter
    Oculogenetic Unit,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • C. Kostic
    Oculogenetic Unit,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • M. Tekaya
    Oculogenetic Unit,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • D.F. Schorderet
    Institute of Research in Ophtalmology, Sion, Switzerland
  • L. Zografos
    Dept of Ophtalmology,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • F.L. Munier
    Oculogenetic Unit,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • Y. Arsenijevic
    Oculogenetic Unit,
    Jules Gonin Eye Hospital, Lausanne, Switzerland
  • Footnotes
    Commercial Relationships  O. Grüter, None; C. Kostic, None; M. Tekaya, None; D.F. Schorderet, None; L. Zografos, None; F.L. Munier, None; Y. Arsenijevic, None.
  • Footnotes
    Support  Provisu
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4773. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      O. Grüter, C. Kostic, M. Tekaya, D.F. Schorderet, L. Zografos, F.L. Munier, Y. Arsenijevic; Potential Improvement of Lentiviral Gene Transfer by Weakening The Extracellular Matrix . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4773.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Gene transfer seems to offer a substantial promise for the therapy of degenerative ocular diseases. Lentiviral vectors have the ability to transduce efficiently murine photoreceptors (PR) during the first days of life, but they are poorly effective on PR during adulthood (Kostic et al. (2003)). Previous studies have described the abilities of enzymes (chondroitinase ABC (CA) and neuraminidase (NM)) to change the structure of the interphotoreceptor matrix (IPM) and to increase the retinal detachment when subretinally injected without affecting retinal function after recovery (Yao et al. (1992)) . Considering the IPM as a physical barrier that may decrease photoreceptor transduction, we injected into the subretinal space of the mouse different enzymes simultaneously with the lentiviral vector preparation to increase the viral transduction by fragilizing the IPM. Methods: NM or CA and the lentiviral vector LV–Rho–GFP expressing GFP under the control of the rhodopsin promoter were simultaneously injected into the subretinal space of adult DBA mice. The animals were sacrificed 7 days post–injection and eyes were processed by cryostat sectioning and analysed by fluorescent microscopy. Results: Subretinal injection of NM and CA induces modifications in the IPM of the mouse as previously described in the rabbit (Yao et al. (1990)). The simultaneous subretinal injection of NM and LV–Rho–GFP increases markedly and significantly the number of transduced PR (more than 4 fold) and is correlated with an increase of the retinal detachment. CA effect has a similar tendancy but the increase is not statistically significant. Conclusions: The lentiviral transduction is improved when simultaneously injected into the subretinal space of the mouse with the NM. Among the enzyme properties, the increase of the retinal detachment appears to facilitate the lentiviral transduction. This technique seems to be very promising for increasing the lentiviral vector diffusion into the subretinal space. Nevertheless, the transduction density is not increased at a precise point of the retina and complementary studies of the IPM should be made to identify and better understand the factor which limits the PR transduction by lentiviral vectors.

Keywords: gene transfer/gene therapy • photoreceptors • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×